Does newest immunomodulative treatment in patients with psoriasis impact growth and transformation of melanocytic nevi in patients with psoriasis? Preliminary results from a prospective cohort study
Folia Medica Cracoviensia · 11.06.2026 · 66 (1) · 59-68
DOI: 10.24425/fmc.2026.158985 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Folia Medica Cracoviensia, online erschienen am 11.06.2026. Verfasst von Marta Kacprzyk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Stefan Zeromski Municipal Hospital; Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krak…. Hauptthemen laut MEDLINE: Psoriasis, Nevus, Pigmented, Skin Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Patients with psoriasis treated with biologic therapy are considered to have increased risk of developing skin neoplasms. The impact of novel therapies on the development and biology of melanocytic lesions is not completely known. The aim of the study was assess if the treatment with biologics exerts effects on the melanocytic nevi. Material and Methods: Dermoscopy and videodermoscopic imaging of 276 melanocytic lesions were performed at the initial visit and after one year in 13 patients with psoriasis treated with IL-12/23 inhibitors, IL-23 inhibitors or IL-17 inhibitors.
Results
The nevi size significantly increased at the one-year follow-up in the whole study group and in patients treated either with IL-23 inhibitors or IL-12/23 inhibitor. 2% of melanocytic nevi showed an increase in any of the scores (ABCD score, 7-Point Checklist score, CASH score) or at least 1-mm change in the diameter at the one-year follow-up; however, these changes were not statistically significant between the different therapy groups.
Conclusions
Although treatment with novel groups of biologics leads to an increase in nevi size, it does not contribute to significant structural or color changes in melanocytic nevi or to the development of dysplastic nevi or melanoma at the one-year follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Stefan Zeromski Municipal Hospital; Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Poland.
- Department of Surgical Oncology, 5th Military Clinical Hospital in Krakow; National Institute of Oncology, Maria Skłodowska-Curie Memorial, Warsaw, Poland.
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University; Department of General, Oncological, Metabolic and Emergency Surgery,University Hospital in Krakow, Poland.
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University; Department of Surgical Oncology, 5th Military Clinical Hospital in Krakow; National Institute of Oncology, Maria Skłodowska-Curie Memo…
Zitieren
APA
Kacprzyk, M., Masajda, M., Kulbat, A., Richter, K., Brzewski, P., & Wysocki, W. M. (2026). Does newest immunomodulative treatment in patients with psoriasis impact growth and transformation of melanocytic nevi in patients with psoriasis? Preliminary results from a prospective cohort study. Folia Medica Cracoviensia, 66(1), 59-68. https://doi.org/10.24425/fmc.2026.158985
Vancouver
Kacprzyk M, Masajda M, Kulbat A, Richter K, Brzewski P, Wysocki WM. Does newest immunomodulative treatment in patients with psoriasis impact growth and transformation of melanocytic nevi in patients with psoriasis? Preliminary results from a prospective cohort study. Folia Medica Cracoviensia. 2026;66(1):59-68. doi:10.24425/fmc.2026.158985
BibTeX
@article{Kacprzyk2026,
author = {Kacprzyk, Marta and Masajda, Magdalena and Kulbat, Aleksandra and Richter, Karolina and Brzewski, Paweł and Wysocki, Wojciech M},
title = {Does newest immunomodulative treatment in patients with psoriasis impact growth and transformation of melanocytic nevi in patients with psoriasis? Preliminary results from a prospective cohort study},
journal = {Folia Medica Cracoviensia},
year = {2026},
volume = {66},
number = {1},
pages = {59--68},
doi = {10.24425/fmc.2026.158985}
}
EUVIMED